Irritable Bowel Syndrome (IBS), and other persistent visceral pain syndromes such as interstitial cystitis/painful bladder syndrome present a heterogeneous group of patients with often overlapping symptoms. We hypothesize that biologically determined subsets of IBS patients are composed of distinct clusters of biological and behavioral endophenotypes. Some of the involved endophenotypes show sex-related differences, biasing most of these syndromes towards female predominance. Our SCOR research during the past funding period has enabled us to generate a group of testable candidate endophenotypes, many with sex differences, that relate to important clinical characteristics in functional GI disorders. We propose to test the general hypothesis that distinct subgroups of patients can be identified in a population meeting IBS symptom criteria using a phenomics approach in three Aims.
In Aim A, we will prospectively perform comprehensive endophenotyping of 120 IBS patients (60 women). Multimodal brain imaging and psychophysiological techniqes, together with behavioral measures will be used to identify central endophenotypes related to stress hyperresponsiveness, pain sensitivity and cognitive modulation. These endophenotypes will be combined in a comprehensive data base with neuroendocrine (including HPA axis parameters studied in Project 1), and peripheral endophenotypes (including visceral adipose tissue [VAT] and adipokines, studied in Project 2).
In Aim B, we will use interventional phenotyping using a corticotropin releasing factor type 1 receptor (CRF-R1) antagonist in 60 female IBS patients to test the hypothesis that a subgroup of IBS patients with an upregulated CRF/CRF-R1 signaling system can be identified by their responsiveness to a selective CRF-R1 antagonist, while other subgroups show minimal or no response.
In Aim C we will apply advanced mathematical modeling techniques to identify patient subgroups from endophenotypes identified in Aims A and B to test the hypotheses that subgroups of IBS patients can be identified based on unique clusters of endophenotypes, that some of these endophenotypes are responsible for the greater female prevalence of IBS and related syndromes.

Public Health Relevance

Irritable bowel syndrome is a common disorder of considerable human and financial impact, with inadequate treatment options. Identification of objective and biologically based subgroups of irritable bowel syndrome patients is essential to improving the development of targeted, effective treatments for this disorder.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-EMNR-Q)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Los Angeles
United States
Zip Code
Fang, Kai; Law, Ivy Ka Man; Padua, David et al. (2018) MicroRNA-31-3p Is Involved in Substance P (SP)-Associated Inflammation in Human Colonic Epithelial Cells and Experimental Colitis. Am J Pathol 188:586-599
Henström, Maria; Diekmann, Lena; Bonfiglio, Ferdinando et al. (2018) Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome. Gut 67:263-270
Videlock, Elizabeth J; Mahurkar-Joshi, Swapna; Hoffman, Jill M et al. (2018) Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation. Am J Physiol Gastrointest Liver Physiol 315:G140-G157
Bonfiglio, Ferdinando; Zheng, Tenghao; Garcia-Etxebarria, Koldo et al. (2018) Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome. Gastroenterology 155:168-179
Park, S H; Naliboff, B D; Shih, W et al. (2018) Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response. Neurogastroenterol Motil 30:
Martin, Clair R; Osadchiy, Vadim; Kalani, Amir et al. (2018) The Brain-Gut-Microbiome Axis. Cell Mol Gastroenterol Hepatol 6:133-148
Addante, Raymond; Naliboff, Bruce; Shih, Wendy et al. (2018) Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals. J Clin Gastroenterol :
Gupta, Arpana; Woodworth, Davis C; Ellingson, Benjamin M et al. (2018) Disease-Related Microstructural Differences in the Brain in Women With Provoked Vestibulodynia. J Pain 19:528.e1-528.e15
Gupta, Arpana; Mayer, Emeran A; Labus, Jennifer S et al. (2018) Sex Commonalities and Differences in Obesity-Related Alterations in Intrinsic Brain Activity and Connectivity. Obesity (Silver Spring) 26:340-350
Tache, Yvette; Larauche, Muriel; Yuan, Pu-Qing et al. (2018) Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract. Curr Mol Pharmacol 11:51-71

Showing the most recent 10 out of 219 publications